Laparoscopic retroperitoneal hysteropexy. A randomized trial.
To assess the clinical applicability, safety and initial efficacy of a new laparoscopic retroperitoneal hysteropexy technique. A relatively homogeneous group of patients (N = 62) with symptomatic uterine retroflexion was randomly allocated to laparoscopic retroperitoneal uterine suspension (n = 32, group I) and diagnostic laparoscopy (n = 30, group II). Patients from both groups were followed for at least 24 months. The following clinical parameters were compared between groups I (treated) and II (untreated): deep dyspareunia, dysmenorrhea, sense of bladder pressure with frequent urination and sense of pressure in the rectum. Surgery was performed as an outpatient operation by the author. Intraoperative or postoperative complications were not observed in either group. A prospective, double-blind, controlled trial revealed that 87.5% of patients with symptomatic uterine retroflexion experienced relief from symptoms after the operation. Statistical analysis of the two groups documented that clinical symptoms improved (with P < .0001) in a statistically significant number of cases among patients subjected to hysteropexy. Laparoscopic retroperitoneal uterine suspension benefitted patients and was safe.